Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ANPCYNASDAQ:BIAFWOTCMKTS:DSRLF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeANPCYANGLEC$0.90-7.4%C$0.98C$0.74▼C$2.44N/AN/A1,463 shs201 shsBIAFWbioAffinity Technologies$0.14-1.4%$0.15$0.10▼$2.90N/AN/A8,601 shs389 shsDSRLFDiaSorin$107.68-0.9%$106.98$100.01▼$112.30N/A-0.02106 shs170 shs20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceANPCYANGLE0.00%-7.45%-18.64%-15.17%-62.55%BIAFWbioAffinity Technologies0.00%-1.38%+10.00%-41.39%-72.50%DSRLFDiaSorin0.00%-0.90%+2.85%-1.75%-1.21%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationANPCYANGLEN/AN/AN/AN/AN/AN/AN/AN/ABIAFWbioAffinity TechnologiesN/AN/AN/AN/AN/AN/AN/AN/ADSRLFDiaSorinN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceANPCYANGLE 0.00N/AN/AN/ABIAFWbioAffinity Technologies 0.00N/AN/AN/ADSRLFDiaSorin 2.00HoldN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookANPCYANGLEN/AN/AN/AN/AN/AN/ABIAFWbioAffinity Technologies$8.81MN/AN/AN/AN/AN/ADSRLFDiaSorin$1.24BN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateANPCYANGLEN/A-C$0.48N/A∞N/AN/AN/AN/AN/ABIAFWbioAffinity TechnologiesN/AN/A0.00∞N/AN/AN/AN/AN/ADSRLFDiaSorin$173.01MN/A0.00∞N/AN/AN/AN/A7/28/2025 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthANPCYANGLEN/AN/AN/AN/AN/ABIAFWbioAffinity TechnologiesN/AN/AN/AN/AN/ADSRLFDiaSorinN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipANPCYANGLEN/ABIAFWbioAffinity TechnologiesN/ADSRLFDiaSorinN/AInsider OwnershipCompanyInsider OwnershipANPCYANGLEN/ABIAFWbioAffinity TechnologiesN/ADSRLFDiaSorinN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableANPCYANGLE173N/AN/ANot OptionableBIAFWbioAffinity Technologies10N/AN/ANot OptionableDSRLFDiaSorin3,186N/AN/ANot OptionableDSRLF, ANPCY, and BIAFW HeadlinesRecent News About These CompaniesShort Interest in DiaSorin S.p.A. (OTCMKTS:DSRLF) Rises By 68.9%June 15, 2025 | marketbeat.comDiaSorin (OTCMKTS:DSRLF) Shares Up 7.3% - Here's What HappenedJune 13, 2025 | marketbeat.comDiaSorin (OTCMKTS:DSRLF) Reaches New 1-Year High - Here's What HappenedJune 12, 2025 | marketbeat.comDiaSorin S.p.A. (OTCMKTS:DSRLF) Short Interest Up 32.6% in MayJune 3, 2025 | marketbeat.comDiaSorin S.p.A. Receives Buy Rating from Dylan Van Haaften Due to Strong Market Position and Financial PerformanceMay 7, 2025 | tipranks.comDiaSorin: Anticipate A Double-Digit EBITDA Growth RateMay 2, 2025 | seekingalpha.comDiaSorin S.p.A. (0GZX) Receives a Hold from BarclaysMarch 25, 2025 | markets.businessinsider.comDiaSorin S.p.A. (0GZX) Receives a Sell from Kepler CapitalMarch 19, 2025 | markets.businessinsider.comDiaSorin stock rises despite mixed financial resultsMarch 17, 2025 | in.investing.comDiaSorin S.p.A. (DSRLF) Q4 2024 Earnings Call TranscriptMarch 14, 2025 | seekingalpha.comItaly's DiaSorin ex-Covid revenue in line with guidanceMarch 14, 2025 | reuters.comUBS Remains a Hold on DiaSorin S.p.A. (0GZX)March 6, 2025 | markets.businessinsider.comKepler Capital Sticks to Its Sell Rating for DiaSorin S.p.A. (0GZX)March 5, 2025 | markets.businessinsider.comDiaSorin S.p.A. (0GZX) Receives a Hold from RBC CapitalFebruary 27, 2025 | markets.businessinsider.comDeutsche Bank sets DiaSorin stock Buy rating, €121 targetFebruary 11, 2025 | msn.comGlobal Health Update: DiaSorin Leads Diagnostic Surge While RSV and Allulose Make WavesNovember 6, 2024 | devdiscourse.comDiagnostics group DiaSorin's nine-month adjusted core profit up 6%November 5, 2024 | msn.comKepler Capital Reaffirms Their Sell Rating on DiaSorin S.p.A. (0GZX)October 27, 2024 | markets.businessinsider.comDSRLF DiaSorin S.p.A.September 27, 2024 | seekingalpha.comDiaSorin S.p.A. (DSRLF) Q2 2024 Earnings Call TranscriptJuly 31, 2024 | seekingalpha.comDiaSorin SpA ADR (DASOY)May 23, 2024 | investing.comMedia Sentiment Over TimeDSRLF, ANPCY, and BIAFW Company DescriptionsANGLE OTCMKTS:ANPCYC$0.90 -0.07 (-7.45%) As of 06/20/2025 11:02 AM EasternANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.bioAffinity Technologies NASDAQ:BIAFW$0.14 0.00 (-1.45%) As of 06/20/2025 03:18 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level. The company was incorporated in 2014 and is based in San Antonio, Texas.DiaSorin OTCMKTS:DSRLF$107.68 -0.98 (-0.90%) As of 06/20/2025 02:22 PM EasternDiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Microsoft Stock Holds Steady as AI Drives Workforce Shift Top International ETFs With Dividends and Market-Beating Returns D-Wave Goes International With South Korea Partnership BigBear.ai Poised to Benefit as Palantir Dominates AI Defense Kroger Stock Confirms Buy Signal as Uptrend Gains Strength Darden Stock Set to Sizzle After Blowout Q4 and $1B Buyback Alphabet’s Comeback: The Hidden Engines Powering Google New All-Time Highs Coming for Broadcom? Wall Street Says Yes Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
